Nov 25, 2021 / 10:00PM GMT
Steven Newman - EROAD Limited - MD, CEO & Executive Director
(technical difficulty)
The first half of FY '22 results. I think we've got most people in. So we will begin.
So it's been a solid half year, definitely very challenging macroeconomic conditions impacting all 3 markets. That said, we did see some growth. Alex will talk more about that. When you do a comparison year-on-year, it was $1.6 million of grants given around COVID in North America, which didn't happen this year. So the growth year-on-year, excluding that one-off, is the $2.2 million plus $1.6 million.
In terms of EBITDA, we're at $12.6 million. That includes $2 million of transaction and integration costs relating to the Coretex acquisition. So there are a number of one-offs that did clear in this half year. When Alex gets to those, you'll get to see what the accounting number is and what that normalizes with the removal of the one-offs.
In terms of AMRR, an increase year-on-year from $88.4 million to $92.9 million. Contracted unit growth, 6,500. Improvement round ARPU of $0.66, but when it's
Half Year 2022 EROAD Ltd Earnings Call Transcript
Nov 26, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers